Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cartesian Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 66 | 68 | +2 |
| Shares | 6.40M | 5.99M | −406.6K (−6.4%) |
| Value | $66.5M | $60.9M | −$5.57M (−8.4%) |
New holders (6)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 25,357 | $259.1K | 0.00% |
| Bridgeway Capital Management, LLC | 25,000 | $255.5K | 0.01% |
| SRS Capital Advisors, Inc. | 111 | $1.14K | 0.00% |
| Optiver Holding B.V. | 80 | $818 | 0.00% |
| Larson Financial Group LLC | 3 | $31 | 0.00% |
| XTX Topco Ltd | 26,259 | $0 | 0.00% |
Sold out (4)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Delphi Financial Group, Inc. | 22,028 | $228.9K |
| Renaissance Technologies LLC | 19,500 | $202.6K |
| National Bank of Canada | 40 | $415 |
| Allworth Financial LP | 15 | $156 |